Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluating stereotactic radiation therapy with ipilimumab for metastatic melanoma has completed, with results posted.
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ILB2109 in combination with toripalimab in patients with advanced solid malignancies, currently recrui…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors [Phase 1]
Phase I trial update of T cells engineered to express an anti-GD2 chimeric antigen receptor in children and young adults with GD2-positive s…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: MB-CART20.1 Melanoma [EARLY_Phase 1]
Miltenyi Biomedicine's MB-CART20.1 trial for melanoma (early-phase 1) has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Etude rétrospective Monocentrique MATRIX
A retrospective monocentric study named MATRIX focusing on melanoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2024-05-14Clinical Trial Update: iToBoS: Clinical Data Acquisition Study [NA]
This entry reports an update on the iToBoS clinical data acquisition study sponsored by The University of Queensland, involving melanoma; th…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors [NA]
A completed clinical trial evaluated a wearable device designed to improve sun-protection behaviors in melanoma survivors, and results have …
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 [Phase 1]
A first-in-human Phase 1 trial of BMC128 in combination therapy evaluating a single dose level, across multiple cancers; status is active bu…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With Pembrolizumab
Retrospective analysis of melanoma patients treated with pembrolizumab evaluating response markers and adverse events to understand associat…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Nivo/Ipi Combination Therapy in Symptomatic Brain Metastases [Phase 2]
Phase 2 clinical trial evaluating the nivolumab and ipilimumab combination in symptomatic melanoma with brain metastases has been terminated…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma Patients
This completed clinical trial update investigates elevated LDH serum levels and FDG-PET imaging findings in patients with metastatic melanom…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy.
Clinical trial update reporting on predictive parameters for colitis in melanoma patients treated with immunotherapy.
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
This clinical trial update describes a biobank and patient registry for aggressive tumors to support translational and analytical research; …
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: [18F]Dabrafenib Molecular Imaging in Melanoma Brain Metastasis [NA]
The trial evaluating the radiolabeled imaging agent [18F]Dabrafenib for detecting melanoma brain metastases has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors
A completed clinical trial evaluates quality of life and physical fitness in patients treated with immune checkpoint inhibitors for melanoma…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: PD-L1 PET Imaging in Melanoma Patients [NA]
A completed clinical trial assessing PD-L1 PET imaging in patients with melanoma, sponsored by University Medical Center Groningen.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: IL2 Imaging in Metastatic Melanoma [NA]
A clinical trial studying IL-2 imaging for metastatic melanoma conducted by University Medical Center Groningen has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma [Phase 1, Phase 2]
A phase 1/2 study evaluating the monoclonal antibody KW-2871 in patients with Stage IV melanoma has been terminated.
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors
This is a clinical cohort study at University Medical Center Groningen evaluating patients with melanoma and non-small cell lung cancer who …
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Pembrolizumab-PET Imaging [NA]
This clinical trial update notes the completion of a pembrolizumab-PET imaging study involving melanoma and non-small cell lung cancer.
-
CLINICAL_TRIALS other · 2024-05-02Clinical Trial Update: Neoadjuvant Combination Immunotherapy for Stage III Melanoma [Phase 2]
A Phase 2 neoadjuvant immunotherapy trial for stage III melanoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery [Phase 2]
A Phase 2 study evaluating ASP5354 to visualize sentinel lymph nodes during surgery in breast cancer or melanoma was terminated. Results hav…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma [Phase 2]
A Phase 2 study evaluating IMM-101 in combination with checkpoint inhibitor therapy for advanced melanoma has completed, with results posted…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion [Phase 1, Phase 2]
A clinical trial evaluating nivolumab for melanoma patients with in-transit metastases treated by isolated limb perfusion, currently in Phas…
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response [Phase 4]
Phase 4 trial updating nivolumab dose optimization in melanoma patients who have complete, partial, or stable response.